Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
2,244 total articles
Alphabet's scale in cloud, search, and multimodal AI gives it a clearer path to near-term monetization than Apple's device-first approach. Valuation, cash flow and technicals create an actionable long trade: enter near $300, stop at $281, target $350 over the next 45 trading days while watching cloud customer growth and Gemini monetization as catal…
Gencor (GENC) sits on a $57.4 million backlog and $147.7 million in cash and securities with no debt. That mix - an orderbook large relative to trailing annual sales and a net-cash balance sheet - supports a long trade into fiscal 2026 as order conversion resumes. Entry $15.14, stop $13.50, target $20.00, long-term (180 trading days).
Nu Skin (NUS) trades at depressed multiples despite positive free cash flow, a modest debt load, and returns on capital consistent with a healthy business. This trade idea lays out a long trade with defined entry, stop, and target using current valuation and technical context - the idea is to own the stock while management executes on customer acqu…
Electrolux's recent margin improvement, reinforced by SEK 4.0bn in cost efficiency gains and Q4 operating margin expansion to 4.3%, suggests earnings upside that the market has not fully priced. With a $2.51B market cap, benign technicals and an improving product footprint in North America, ELUXY looks like a mid-term long trade. Entry $17.90, stop…
Viavi has moved beyond a pure telecom-capex rebound. Q2 strength, upbeat guidance and expanding addressable markets in AI, data-center testing and defense/aerospace make the stock a tactical long. The trade uses a precise entry at $26.32, a stop at $22.00 and a $37.00 target over a 180 trading-day horizon.
Vanda (VNDA) is a small-cap pharma with a pending regulatory event this week that could re-rate the stock. At roughly $6, market-implied valuation is modest (EV/Sales ~1.3) but fundamentals and technicals are weak. This is a high-risk, event-driven trade: defined-entry long before PDUFA with a tight stop and an upside target near prior highs.
Ares Capital (ARCC) looks vulnerable. High exposure to software & services, signs of lingering credit deterioration, and an environment of falling rates that erodes BDC yield economics create a trifecta that can pressure the stock and the dividend. Valuation (P/B ~0.97, P/E ~10.7, market cap ~$13.9B) discounts some risk, but not all. Trade idea: sh…
NerdWallet (NRDS) looks undervalued relative to its cash generation and growth profile. At about $10 a share, P/E near 10 and EV/sales below 1, the stock offers an asymmetric reward-to-risk for a mid-term swing. This trade idea outlines an entry, stop, and target with clear catalysts and risks to watch.
Expand Energy (EXE) looks like the opening chapter of a turnaround: attractive cash-flow generation, modest leverage, and a materially lower share price from late-2025 highs. The chart is beaten down but not broken; risk-reward favors a controlled long position with a $95 stop and staged upside targets at $110 and $125 over the next 45 to 180 tradi…
Delta offers a compelling risk-reward setup: steady free cash flow ($3.84B), falling leverage (debt/equity ~0.73), and undervalued multiples (P/E ~9.3, EV/EBITDA ~4.0). This trade targets a re-rating to ~12-13x EPS over the next 180 trading days, with a clear stop to protect against cyclical shocks.
Louisiana-Pacific (LPX) looks like a quality building-materials name trading below recent momentum. The company combines low net leverage, positive free cash flow and strong brand positions in engineered siding and OSB. Technicals and a stretched P/E argue for a tactical entry rather than a buy-and-hold. Trade idea: enter at $86.27, stop $79.00, ta…
AutoNation (AN) looks like a buy for a mid-term swing trade. The business is generating strong earnings power (adjusted EPS strength and high ROE), valuation is reasonable on a P/S and EV/EBITDA basis, and buyback optionality could catalyze a re-rating. Key risks include elevated leverage, negative free cash flow, and auto-cycle sensitivity. Trade …
Palantir's price action is carving a technical base near the 10-day SMA as volume and short activity remain elevated. With recent government wins and strong commercial growth supporting fundamentals, intermediate-term options activity appears to favor a bullish tilt. This trade targets a measured upside while respecting elevated valuation and near-…
Uber trades at $72.91 with a $151B market cap, double-digit FCF and a durable platform moat. With early commercial robotaxi launches, partnerships with autonomous and chip leaders, and expansion into new delivery markets, Uber is positioned to capture a winner-take-most outcome in on-demand mobility. This trade idea lays out an actionable long trad…
Enterprise Products Partners (EPD) is a large, cash-rich midstream operator trading at $36.11 with a ~6.0% yield, 27+ years of distribution increases, and solid 2025 cash flow metrics. Fundamentals and technicals favor a controlled long trade: entry $36.11, stop $34.00, target $40.00 over a long-term horizon (180 trading days).
Expand Energy's Class C warrants present a tactical buying opportunity after the recent post-earnings dip. The company combines Haynesville LNG-exposed production with Appalachian supply to population centers, sits with low net leverage and surprisingly large free cash flow, and shows bullish momentum indicators. Enter on weakness with a tight stop…
Cloudflare's recent results and partnerships point to sustained AI-driven edge traffic and higher-margin compute usage through Cloudflare Workers. The market has already rewarded the story, but fundamentals - 34% revenue growth, record deal pace, and doubled free cash flow - support further upside. This is a position trade: enter at $192.00, stop $…
Genpact looks attractively positioned: accelerating demand for advanced technology services (ATS), improving margins and healthy free cash flow support upside from a $39 handle. Valuation is reasonable (P/E ~12, EV/EBITDA ~8.4), balance sheet is solid and the company pays a modest dividend - we lay out an actionable long trade with entry, stop and …
Atlassian has been punished alongside other software names, but underlying cash flow and a rebuilding book of deferred revenue (RPO) argue for a recovery. Entry at $84.34, stop at $74.00, target $180.00 over a 180 trading-day horizon. This is a high-conviction trade that balances clear upside against execution and macro risk.
Travel + Leisure (TNL) is extending a momentum run that put the stock at a fresh 52-week high of $81.00. With solid free cash flow ($506M), a P/E near 12 and a 3% yield, this is a tactical long for traders who want momentum exposure with defined risk. Plan: enter at $75.00, stop $71.00, target $82.00 over a mid-term (45 trading days) holding period…
CRISPR Therapeutics (CRSP) is a classic binary biotech: tangible commercial traction with Casgevy ($116M annual run-rate and accelerating patient starts) meets a deep pipeline and in vivo ambitions. At a ~$5.15B market cap, the stock already discounts meaningful upside but still trades on clinical outcomes and adoption. This trade idea favors a spe…
Enterprise Products Partners (EPD) offers a rare combination for income investors: double-digit free cash flow, a multi-decade distribution growth streak, and a high single-digit yield in a defensive midstream franchise. We lay out a concrete trade: entry at $36.25, stop loss $34.50, target $40.50, with a swing horizon of 45 trading days. The thesi…
BDRAF popped into focus after a 13.9% gap up to $194.67 and tightening moving averages. Short interest has collapsed from 8,488 shares (22.76 days to cover) on 12/31/2025 to 668 shares (1 day to cover) on 01/30/2026, a dynamic that often accelerates rallies when combined with bullish technicals. We rate BDRAF a buy for a long-term trade (180 tradin…
Incyte is trading at roughly a 15.7x P/E with steady free cash flow generation and meaningful upside if Opzelura and Niktimvo continue to scale. Given a $20.5B market cap, $1.35B in free cash flow and neutral technicals, a disciplined long with a $103 entry, $92 stop and $130 target over 180 trading days offers an asymmetric reward-to-risk profile.
AeroVironment sits at the intersection of rising Drones-as-a-Service demand, defense spending tailwinds, and advanced R&D in sensors and communications. The stock has stabilized after a sharp correction tied to a government stop-work order; fundamentals show scale, a $14.3B market cap, and meaningful cash, but earnings remain negative and free cash…
